TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Gross profit 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) annual gross profit history from SEC filings — each fiscal year as reported.
$8.9BFY2025 · since FY2016: $11.7B → $8.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.9B | +10.8% |
| FY2024 | $8.1B | +5.5% |
| FY2023 | $7.6B | +9.6% |
| FY2022 | $7.0B | -8.2% |
| FY2021 | $7.6B | -1.7% |
| FY2020 | $7.7B | +2.5% |
| FY2019 | $7.5B | -9.1% |
| FY2018 | $8.3B | -21.8% |
| FY2017 | $10.6B | -8.9% |
| FY2016 | $11.7B | — |
Source: SEC XBRL filings · For reference only · Not investment advice